Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01257958 · ClinicalTrials.gov registry record · Phase 1
Vitamin D Pilot Study in Patients With Multiple Sclerosis
A Phase 1 study of Relapsing Remitting Multiple Sclerosis, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 1
- Development phase
- 1
- Study location
NCT01257958 is a Phase 1 study of Relapsing Remitting Multiple Sclerosis that has completed, run by University of Wisconsin, Madison. The trial reports 1 study location across 1 state.
The verdict
NCT01257958, a Phase 1 study of Relapsing Remitting Multiple Sclerosis, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 1
- Study location
Study Summary
Phase 1 study of 19-nor Vitamin D in relapsing-remitting MS. Primary measure is MRI.
Conditions Studied
Interventions
- DRUG 19 nor vitamin d
Study Locations (1)
Wisconsin
- UW-Madison - Madison
Trial Details
| Field | Value |
|---|---|
| Start Date | 1998-02 |
| Est. Completion | 2000-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01257958
The ClinicalTrials.gov registry entry for NCT01257958 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Relapsing Remitting Multiple Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which 19 nor vitamin d is the first listed.
NCT01257958 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT01257958 about?
NCT01257958 is a clinical study titled "Vitamin D Pilot Study in Patients With Multiple Sclerosis". Phase 1 study of 19-nor Vitamin D in relapsing-remitting MS. Primary measure is MRI.
What is the current status of trial NCT01257958?
This trial is currently completed. It is a Phase 1 study. The study started on 1998-02. Estimated completion is 2000-06.
What conditions does trial NCT01257958 study?
This clinical trial studies the following conditions: Relapsing Remitting Multiple Sclerosis.
What interventions are being tested in trial NCT01257958?
The interventions under investigation include: 19 nor vitamin d (DRUG).
Who is sponsoring clinical trial NCT01257958?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01257958 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Relapsing Remitting Multiple Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
WEBCAMS: Walking Exercise for Brain and Cognition in Adults With Multiple Sclerosis
ACTIVE NOT RECRUITING · Phase 1
-
Safety Study of BIIB033 in Subjects With Multiple Sclerosis
COMPLETED · Phase 1
-
Exploratory Study on the Timing of Multiple Sclerosis (MS) Symptoms
RECRUITING
-
Study to Evaluate the Usability and Value of Integrated Digital Solutions in Medical Care of Participants With Multiple Sclerosis
RECRUITING
-
The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study
RECRUITING · NA
-
Functional Outcomes From Diets in Multiple Sclerosis
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.